BWXT to Restart Existing TRISO Nuclear Fuel Production Line and Expand Capacity

Company to hireup to 60 new workers to attain increased production targets (LYNCHBURG, Va. – Oct. 2, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is in the process of restarting its existing TRISO nuclear fuel production line and is planning to expand its existing capacity within approximately 12 months. The expansion […]

BWXT Promotes Suzy Sterner to Senior Vice President for Government Relations

(LYNCHBURG, Va. – Oct. 1, 2019) – BWX Technologies, Inc. (NYSE: BWXT) is pleased to announce that Suzy Sterner has been promoted to senior vice president for government relations, effective today, Oct. 1, 2019. Sterner is responsible for BWXT’s relationship with the U.S. government, including the U.S. Congress and the executive branch, in addition to […]

BWXT Announces Availability of FDA-Approved Indium In-111 Oxyquinoline Solution

 (LYNCHBURG, Va. – September 26, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT ITG Canada, Inc., having received approval from the U.S. Food and Drug Administration (FDA) on its abbreviated new drug application for its generic version of Indium In-111 Oxyquinoline Solution, is now making the product available for sale in […]

Join the BWXT NEC Toronto Community Liaison Committee!

Local citizens and community organizations are invited to apply to the BWXT Nuclear Energy Canada (BWXT NEC) Community Liaison Committee (CLC). The deadline to apply is December 13, 2019 and new members will be notified in January 2020. The CLC was established in 2013 and its purpose is to create a forum for the exchange of information […]

BWX Technologies Reports Second Quarter 2019 Results With Solid Revenue and EPS Growth

Lynchburg, VA – August 5, 2019 – BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2019 revenue of $471 million, a 7.4% increase compared with $439 million in the second quarter of 2018.  GAAP net income for the second quarter 2019 was $58.9 million, or $0.62 per diluted share, compared […]

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.